- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Metabolic X Syndrome Dyslipidemia
Total 8397 results
-
Merck Sharp & Dohme LLCCompleted
-
Chong Kun Dang PharmaceuticalCompletedDyslipidemiaKorea, Republic of
-
Pronova BioPharmaTerminated
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Hospital de Clinicas de Porto AlegreCompleted
-
Xention LtdCompletedDyslipidemiaDenmark, Netherlands
-
University of California, San DiegoNational Heart, Lung, and Blood Institute (NHLBI)CompletedDyslipidemiasUnited States
-
China Academy of Chinese Medical SciencesCompleted
-
New York Hospital QueensNYHQ Cardiac Health Center; Pivotal TherapeuticsUnknown
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Akros Pharma Inc.Completed
-
University of Nevada, Las VegasCompleted
-
AstraZenecaWithdrawn
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
University of WashingtonUpsher-Smith LaboratoriesCompleted
-
Akros Pharma Inc.Completed
-
Akros Pharma Inc.Completed
-
UCSF Benioff Children's Hospital OaklandNational Cattlemen's Beef AssociationCompletedHealthy | Cardiovascular Disease | Atherogenic DyslipidemiaUnited States
-
Daewon Pharmaceutical Co., Ltd.Completed
-
Orient Pharma Co., Ltd.CompletedPrimary Hypercholesterolemia | Mixed DyslipidemiasTaiwan, Australia, New Zealand
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
AmgenCompletedHyperlipidemia and Mixed DyslipidemiaUnited States, Canada, Denmark, France, Italy, Belgium, Czechia, Taiwan, Japan, Switzerland, Germany, United Kingdom, Korea, Republic of, Hong Kong, Netherlands, New Zealand, South Africa, Australia, Spain, Austria, Hungary, Russian... and more
-
Assiut UniversityUnknownDyslipidemia Associated With Acute Coronary SyndromeEgypt
-
AstraZenecaParexelNot yet recruiting
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedDyslipidemia | Cardiovascular
-
IRCCS Policlinico S. MatteoUniversity of PaviaCompleted
-
Gateway Health AllianceUniversity of YaoundeCompletedObesity | Metabolic Syndrome | DyslipidemiaCameroon
-
University Hospital, MontpellierUniversity Hospital, ToulouseRecruitingPatient With DyslipidemiaFrance
-
University of PaviaFoundation IRCCS San Matteo HospitalRecruiting
-
Shenzhen Center for Chronic Disease ControlSun Yat-sen University; Shenzhen Qilinshan SanatoriumCompletedDyslipidemia | Dysglycemia
-
University Medical Centre LjubljanaCompletedDyslipidemia | TransplantsSlovenia
-
PfizerWithdrawnPrimary Hyperlipidemia or Mixed DyslipidemiaChina
-
Yuhan CorporationCompletedDyslipidemia & HypertensionKorea, Republic of
-
Temple UniversityAlmond Board of CaliforniaCompletedHypertension | Obesity | Hyperlipidemia | Metabolic Syndrome XUnited States
-
University of LausanneUniversity Hospital Inselspital, Berne; Centre Hospitalier Universitaire VaudoisCompletedObesity | Metabolic Syndrome | DyslipidemiaSwitzerland
-
AstraZenecaParexelRecruiting
-
GWT-TUD GmbHActive, not recruitingDyslipoproteinemiasGermany
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderPoland, Ukraine, United Kingdom
-
AmgenCompletedPrimary Hyperlipidemia and Mixed DyslipidemiaAustralia
-
Solvay PharmaceuticalsCompletedDyslipidemia/Glucose Metabolism DisorderCzech Republic, France, Hungary, India, Lithuania, Poland, Slovakia
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Chong Kun Dang PharmaceuticalCompletedHypertension and DyslipidemiaKorea, Republic of
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With DyslipidemiaKorea, Republic of
-
Organon and CoCompleted